Fact CheckerSign in

NCT06840223Completed

Thoracolumbar Fascia Release on Pulmonary Function in Stroke

Immediate Effects of Thoracolumbar Fascia Release on Pulmonary Function in Stroke Patients: a Randomized Controlled Study

Source: ClinicalTrials.gov · Last updated 21 Feb 2025

Brief summary (registry, in English)

This study looks at how thoracolumbar fascia release affects breathing in people who had a stroke. After a stroke, many people have trouble breathing well because their muscles become stiff. We want to see if releasing the thoracolumbar fascia (a big sheet of tissue in the lower back) can help improve lung function. Participants will be divided into three groups: Control group - Receives standard stroke rehabilitation. Breathing exercise group - Gets standard rehabilitation plus breathing exercises. Thoracolumbar fascia release group - Gets standard rehabilitation plus thoracolumbar fascia release therapy. We will measure lung function right after a single session to see if this therapy makes breathing easier. Our primary outcome is to check if thoracolumbar fascia release improves lung function compared to the other groups. This study hopes to find new ways to help stroke survivors breathe better and feel more comfortable.

Status (registry)
Completed
Study type
Interventional
Enrollment
42 (actual)
First submitted
17 Feb 2025
Start date
1 Nov 2022
Primary completion date
1 Jun 2024
Lead sponsor
Kocaeli Sağlık ve Teknoloji Üniversitesi
Diseases
Stroke
NCT number
NCT06840223

What you commit to

  • Study type: Interventional
  • Participants enrolled: 42
  • From 1 Nov 2022 to the primary completion date, 1 Jun 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe cardiorespiratory or neuromuscular disease, tracheostomy, obesity (BMI ≥30 kg/m²), rib cage deformity, cognitive impairment (Mini-Mental State Examination score ≤ 20), and severe dysphagia, aphasia or confusion.

Who the study is looking for

  • Eligible participants were male patients aged 18-65 years, diagnosed with monohemispheric ischemic stroke above the brainstem, confirmed through computed tomography or magnetic resonance imaging and a stroke diagnosis at least six months prior to the study.

Age in the registry: 18 years to 65 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kocaeli Sağlık ve Teknoloji Üniversitesi
Coordinator of this site? Confirm its status
KocaeliTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.